Apoptosis and Alzheimer disease. Contribution of cellular and transgenic models
Hugon, J.; Esclaire, F.; Terro, F.; Yardin, C.
Revue Neurologique (Paris) 156(2): 123-125
2000
ISSN/ISBN: 0035-3787 PMID: 10743009 Document Number: 519514
Document emailed within 1 workday
Related Documents
Furth, P.A. 1998: SV40 rodent tumour models as paradigms of human disease: transgenic mouse models Developments in Biological Standardization 94: 281-287Matsumoto, M.; Nii, T. 2012: Transgenic approaches to the pathogenesis of autoimmune disease with mouse models of the human disease SEIKAGAKU. Journal of Japanese Biochemical Society 84(12): 1009-1012
Ho, Y.S. 1994: Transgenic models for the study of lung biology and disease American Journal of Physiology 266(4 Pt 1): L319-L353
Gillen, T.E.; Gregg, K.M.; Yuan, H.; Kurth, M.C.; Krishnan, K.R. 2001: Clinical trials in Alzheimer's disease. Calculating Alzheimer's Disease Assessment Scale-cognitive subsection with the data from the consortium to establish a registry for Alzheimer's disease Psychopharmacology Bulletin 35(2): 83-96
Gui, L.; Li, W. 1998: Amyloid protein precursor gene and neuron apoptosis of Alzheimer's disease Zhonghua Yi Xue Za Zhi 78(8): 582-583
Antal, A.; Bodis-Wollner, I. 1993: Animal models of Alzheimer's Parkinson's and Huntington's disease. a minireview Neurobiology 1(2): 101-122
Tu, P.H.; Gurney, M.E.; Julien, J.P.; Lee, V.M.; Trojanowski, J.Q. 1997: Oxidative stress, mutant SOD1, and neurofilament pathology in transgenic mouse models of human motor neuron disease Laboratory Investigation; A Journal of Technical Methods and Pathology 76(4): 441-456
Eustache, F.; Lambert, J. 1996: Neuro-cognitive models of spelling and Alzheimer disease: mutual clarification Revue Neurologique (Paris) 152(11): 658-668
Sarantseva, S.V.; Bol'shakova, O.I.; Timoshenko, S.I.; Rodin, D.I.; Vitek, M.P.; Shvartsman, A.L. 2009: Studying pathogenesis of Alzheimer's disease in a Drosophila melanogaster model: human APP overexpression in the brain of transgenic flies leads to deficit of the synaptic protein synaptotagmin Genetika 45(1): 119-126
Brion, J.P. 1992: Cellular lesions in Alzheimer's disease: structural and molecular analysis Bulletin et Memoires de l'Academie Royale de Medecine de Belgique 147(11-12): 481-489; Discussion: 490-491
Eustache, F.; Desgranges, B.; De-La-Sayette, V.; Lalevee, C.; Giffard, B.; Piolino, P.; Viader, F.; Baron, J.C. 2001: Contribution of positron emission tomography to functional neuroimaging in Alzheimer's disease Revue Neurologique (Paris) 157(4): 377-383
Mackell, J.A.; Ferris, S.H.; Mohs, R.; Schneider, L.; Galasko, D.; Whitehouse, P.; Schmitt, F.; Sano, M.; Thal, L.J. 1997: Multicenter evaluation of new instruments for Alzheimer's disease clinical trials: summary of results. The Alzheimer's Disease Cooperative Study Alzheimer Disease and Associated Disorders 11 Suppl. 2: S65-S69
Fukatsu, R.; Tsuzuki, K.; Hayashi, Y.; Takamaru, Y.; Sasaki, N.; Yoshida, T.; Hatakeyama, Y.; Fuji, N.; Takahata, N. 1997: Recent advances in Alzheimer's disease research--amyloid precursor protein trafficking, processing, and mutations in Alzheimer's disease linked genes Hokkaido Journal of Medical Science 72(1): 3-11
Morris, J.C.; Edland, S.; Clark, C.; Galasko, D.; Koss, E.; Mohs, R.; van Belle, G.; Fillenbaum, G.; Heyman, A. 1993: The consortium to establish a registry for Alzheimer's disease (CERAD). Part IV. Rates of cognitive change in the longitudinal assessment of probable Alzheimer's disease Neurology 43(12): 2457-2465
Morris, J.C.; Mohs, R.C.; Rogers, H.; Fillenbaum, G.; Heyman, A. 1988: Consortium to establish a registry for Alzheimer's disease (CERAD) clinical and neuropsychological assessment of Alzheimer's disease Psychopharmacology Bulletin 24(4): 641-652
Miyakawa, T. 1988: Brain pathology in Alzheimer's disease. Ultrastructure of amyloid fibrils in Alzheimer's disease and Down's syndrome Nihon Rinsho. Japanese Journal of Clinical Medicine 46(7): 1471-1474
Szpak, G.M.; Lechowicz, W.; Lewandowska, E.; Bertrand, E.; Wierzba-Bobrowicz, T.; Gwiazda, E.; Schmidt-Sidor, B.; Dymecki, J. 2001: Neurones and microglia in central nervous system immune response to degenerative processes. Part 1: Alzheimer's disease and Lewy body variant of Alzheimer's disease. Quantitative study Folia Neuropathologica 39(3): 181-192
Götz, Jürgen.; Schild, A. 2003: Transgenic and knockout models of PP2A Methods in enzymology 366: 390-403
Schrauf, R.W.; Iris, M. 2011: A direct comparison of popular models of normal memory loss and Alzheimer's disease in samples of African Americans, Mexican Americans, and refugees and immigrants from the former Soviet Union Journal of the American Geriatrics Society 59(4): 628-636
Babinet, C. 1990: Transgenic mice as models for human diseases La Revue du Praticien 40(20): 1859-1862